Development of an evaluation model to determine disease severity in COVID-19 using basic laboratory markers.

Maki, Ryosuke; Horiuchi, Yuki; Hayashi, Fumiaki; Nojiri, Shuko; Takehara, Ikki; Iwasaki, Yosuke; Miyake, Kazunori; Miida, Takashi; Ai, Tomohiko; Tabe, Yoko

Maki, Ryosuke; Horiuchi, Yuki; Hayashi, Fumiaki; Nojiri, Shuko; Takehara, Ikki; Iwasaki, Yosuke; Miyake, Kazunori; Miida, Takashi; Ai, Tomohiko; Tabe, Yoko.

Maki R; Clinical Laboratory Medicine, Juntendo University Urayasu Hospital, Chiba, Japan.
Horiuchi Y; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hayashi F; Scientific Affairs, Sysmex Corporation, Kobe, Japan.
Nojiri S; Medical Technology Innovation Center, Juntendo University, Tokyo, Japan.
Takehara I; Reagent Engineering, Sysmex Corporation, Kobe, Japan.
Iwasaki Y; Scientific Affairs, Sysmex Corporation, Kobe, Japan.
Miyake K; Clinical Laboratory Medicine, Juntendo University Urayasu Hospital, Chiba, Japan.
Miida T; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ai T; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Tabe Y; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Int J Lab Hematol ; 44(5): e245-e249, 2022 10.

Article in English | MEDLINE | ID: covidwho-1895982

Subject(s)

COVID-19; Biomarkers; Humans; SARS-CoV-2; Severity of Illness Index

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Int J Lab Hematol Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: Ijlh.13912

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google